DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR PEMETREXED DISODIUM
Clinical Trials for Pemetrexed Disodium
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00003711 | Combination Chemotherapy in Treating Patients With Metastatic Solid Tumors | Completed | San Antonio Cancer Institute | Phase 1 | 1997-09-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combination chemotherapy with pemetrexed disodium and irinotecan in treating patients who have metastatic solid tumors. |
| NCT00005636 | Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery | Completed | National Cancer Institute (NCI) | Phase 3 | 1999-11-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if cisplatin is more effective with or without pemetrexed disodium for malignant mesothelioma of the pleura. PURPOSE: Randomized phase III trial to compare the effectiveness of cisplatin with or without pemetrexed disodium in treating patients who have malignant mesothelioma of the pleura that cannot be removed by surgery. |
| NCT00005636 | Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery | Completed | Memorial Sloan Kettering Cancer Center | Phase 3 | 1999-11-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if cisplatin is more effective with or without pemetrexed disodium for malignant mesothelioma of the pleura. PURPOSE: Randomized phase III trial to compare the effectiveness of cisplatin with or without pemetrexed disodium in treating patients who have malignant mesothelioma of the pleura that cannot be removed by surgery. |
| NCT00006007 | LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer | Completed | National Cancer Institute (NCI) | Phase 2 | 2000-12-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining LY231514 plus gemcitabine in treating women who have metastatic breast cancer. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Pemetrexed Disodium
Condition Name
| Condition Name for Pemetrexed Disodium | |
| Intervention | Trials |
| Lung Cancer | 28 |
| Stage IV Non-Small Cell Lung Cancer | 13 |
| Unspecified Adult Solid Tumor, Protocol Specific | 8 |
| Stage IIIA Non-Small Cell Lung Cancer | 7 |
| [disabled in preview] | 0 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
Export unavailable in trial.
Subscribe for complete access.
Condition MeSH
Clinical Trial Locations for Pemetrexed Disodium
Trials by Country
Clinical Trial Progress for Pemetrexed Disodium
Clinical Trial Phase
Clinical Trial Status
Clinical Trial Sponsors for Pemetrexed Disodium
Sponsor Name
